Literature DB >> 31571142

Presence of Seropositive Patients to Trypanosoma cruzi in a Municipality of the Mixtec Sierra of the State of Puebla: A Preliminary Study.

L Zumaquero-Ríos1, J Sarracent-Pérez1, C Sandoval-Ruiz1, R M Aldana-Arnas1, A López-Monteon2, J Torres-Montero2, D Guzmán-Gómez2, A Ramos-Ligonio3.   

Abstract

PURPOSE: The state of Puebla has the social marginalization and ecological conditions for the transmission of infectious agents to be effective. Until a few years ago, the state of Puebla was considered non-endemic to the presence of Trypanosoma cruzi as there are no official reports of chronic cases. The objective of this work was to carry out a preliminary study on the prevalence of anti-T. cruzi antibodies in rural areas of the Huatlatlauca municipality in the Mixtec sierra of the state of Puebla.
METHODS: A total of 196 serum samples from 12 rural localities were tested by using four tests: two enzyme-linked immunosorbent assays, an xenodiagnoses and PCR assay.
RESULTS: Overall, 28 (14.2%) of 196 samples were positive for T. cruzi by ≥ 2 tests (95% CI 6.6-20.8%). Our results suggested that the municipality of Huatlatlauca in the Mixteca Sierra of the state of Puebla is an area with endemic potential for the disease with a high prevalence rate in the adult population and with cases in newborns, these high transmission rates are probably associated with problems of congenital and vector transmission.
CONCLUSION: Additional studies should be conducted to generate adequate campaigns for the control of Chagas disease in this area.

Entities:  

Keywords:  Antibodies; Chagas disease; Puebla state; Seroprevalence; Trypanosoma cruzi

Mesh:

Substances:

Year:  2019        PMID: 31571142     DOI: 10.2478/s11686-019-00118-9

Source DB:  PubMed          Journal:  Acta Parasitol        ISSN: 1230-2821            Impact factor:   1.440


  8 in total

1.  Identification of a hyperendemic area for Trypanosoma cruzi infection in central Veracruz, Mexico.

Authors:  Angel Ramos-Ligonio; Aracely López-Monteon; Daniel Guzmán-Gómez; José Luis Rosales-Encina; Yairh Limón-Flores; Eric Dumonteil
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

2.  Disease: Poverty and pathogens.

Authors:  Michael Eisenstein
Journal:  Nature       Date:  2016-03-17       Impact factor: 49.962

3.  Seroprevalence of Trypanosoma cruzi (TC) and risk factors in Colima, Mexico.

Authors:  Oscar Alberto Newton-Sánchez; Francisco Espinoza-Gómez; Valery Melnikov; Iván Delgado-Enciso; Fabián Rojas-Larios; Eric Dumonteil; Benjamín Trujillo-Hernández; Miriam de la Cruz-Ruiz
Journal:  Gac Med Mex       Date:  2017 Mar - Apr       Impact factor: 0.302

4.  Characterization of the dispersal of non-domiciliated Triatoma dimidiata through the selection of spatially explicit models.

Authors:  Corentin Barbu; Eric Dumonteil; Sébastien Gourbière
Journal:  PLoS Negl Trop Dis       Date:  2010-08-03

Review 5.  Chagas disease (American trypanosomiasis) in Mexico: an update.

Authors:  Alejandro Carabarin-Lima; María Cristina González-Vázquez; Olivia Rodríguez-Morales; Lidia Baylón-Pacheco; José Luis Rosales-Encina; Pedro Antonio Reyes-López; Minerva Arce-Fonseca
Journal:  Acta Trop       Date:  2013-04-30       Impact factor: 3.112

6.  Chagas disease and the london declaration on neglected tropical diseases.

Authors:  Rick L Tarleton; Ricardo E Gürtler; Julio A Urbina; Janine Ramsey; Rodolfo Viotti
Journal:  PLoS Negl Trop Dis       Date:  2014-10-09

7.  Mortality Trends for Neglected Tropical Diseases in the State of Sergipe, Brazil, 1980-2013.

Authors:  Marcos Antônio Costa de Albuquerque; Danielle Menezes Dias; Lucas Teixeira Vieira; Carlos Anselmo Lima; Angela Maria da Silva
Journal:  Infect Dis Poverty       Date:  2017-02-08       Impact factor: 4.520

8.  Barriers to treatment access for Chagas disease in Mexico.

Authors:  Jennifer M Manne; Callae S Snively; Janine M Ramsey; Marco Ocampo Salgado; Till Bärnighausen; Michael R Reich
Journal:  PLoS Negl Trop Dis       Date:  2013-10-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.